Stability of Pentobarbital Hydrogel for Rectal Administration in Pediatric Procedural Sedation

Sephora Belo1, Justine Touchard1, Philippe-Henri Secretan1,2

  • 1Hôpital Universitaire Necker-Enfants Malades, Paris, France.

Hospital Pharmacy
|August 12, 2021
PubMed

Insights

Rectal pentobarbital gel provides effective sedation for pediatric imaging. This ready-to-use hydrogel formulation is chemically stable for at least 90 days under various storage conditions.

Area of Science:

  • Pharmaceutical Sciences
  • Pediatric Anesthesiology
  • Radiology

Background:

  • Pentobarbital is a crucial sedative for pediatric imaging procedures like MRI and CT scans.
  • Limited data exists on the stability and formulation of rectal pentobarbital for clinical use.

Purpose of the Study:

  • To formulate and evaluate the stability of a ready-to-use rectal pentobarbital gel.
  • To ensure a reliable and stable sedative option for pediatric patients.

Main Methods:

  • A pentobarbital sodium hydrogel (25 mg/mL) was formulated and packaged in amber glass bottles.
  • Stability was assessed over 90 days at controlled room temperature (22–25°C) and refrigerated conditions (2–8°C).
  • Evaluations included visual inspection, pH measurement, viscosity assessment, and HPLC analysis.

Main Results:

  • The freshly prepared gel was clear, colorless, and free of particulates with a pH of 9.75–9.83.
  • No significant changes in appearance or pH were observed over 90 days.
  • High-performance liquid chromatography confirmed the chemical stability of the formulation at both storage temperatures.

Conclusions:

  • The 25 mg/mL pentobarbital hydrogel is chemically stable for at least 90 days.
  • This stable formulation can be administered to children for effective and rapid sedation during imaging.
  • The study provides essential data supporting the clinical use of rectal pentobarbital gel.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
348
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
600
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
964
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
41
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
418